Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections

NCT00418951 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: Voriconazole
DRUG: Liposomal amphotericin B
DRUG: Liposomal amphotericin B

Sponsor

M.D. Anderson Cancer Center